Anheuser-Busch InBev SA/NV · BUD · FY2025 Q2 · Calendar Q3 2025

AB InBev: Premium brands and digital growth offset softer volumes

The supplied Q2 analysis supports a qualified growth-through-premiumization thesis: premium and non-alcohol brands and BEES are growing, while declining volumes and weakness in China and Brazil leave the durability of earnings growth uncertain.

Reported Before market openNYSEConsumer Defensive $159.55B market cap
80quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.98 Consensus $0.94
EPS surprise +4.3% Reported versus consensus
Reported revenue — Consensus $15.67B
Revenue surprise — Reported versus consensus

Market reaction

prior-close to event-session close
Stock move -13.3% Event window
SPY move -0.4% Same window
Abnormal move -13.0% Stock minus SPY
Volume 4.6× Versus trailing sessions
Subsequent drift +8.6% Up to 20 sessions
BUDSPY benchmark

Ask FN2 about BUD FY2025 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the supplied Q1 analysis, Q2 retained EBITDA growth and margin expansion but showed slower EBITDA growth (6.5% versus 7.9%) and a smaller volume decline (1.9% versus 2.2%). BEES GMV growth accelerated to 63% from 53%; non-alcohol revenue growth was 33% versus 34%. Management maintained its 2025 EBITDA growth outlook, according to the Q2 analysis.

Guidance delta

Guidance was maintained. The Q2 analysis says management remained confident in achieving its 2025 EBITDA growth target of 4–8%; it does not report a change to that range.

Key takeaways

  • EBITDA increased 6.5% with margin expansion despite a 1.9% volume decline, according to the supplied Q2 analysis.
  • Premium brands and non-alcohol offerings remained important growth drivers; non-alcohol beer revenue grew 33%.
  • BEES marketplace GMV grew 63% year over year to $785 million, according to the analysis.
  • Management expressed confidence in the 2025 EBITDA growth outlook, while volume weakness in China and Brazil remained a headwind.

Management priorities

  • Continue investment in megabrands, premium platforms, and innovations across core and beyond-beer categories.
  • Expand non-alcohol and low- or zero-sugar offerings, and scale BEES and direct-to-consumer channels.
  • Focus on off-trade execution in China and expand the footprint in India; use sports and cultural events for brand activation.

Follow BUD with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
BUD EPS earnings history estimate and actual scatter chart 8 reported fiscal quarters and 1 future estimate-only quarters. Q4 '23 actual $1.64, None Q1 '24 estimate $0.69 Q1 '24 actual $0.75, beat Q2 '24 estimate $0.87 Q2 '24 actual $0.91, beat Q3 '24 estimate $0.90 Q3 '24 actual $0.98, beat Q2 '25 estimate $0.97 Q2 '25 actual $0.99, beat Q4 '25 estimate $0.90 Q4 '25 actual $0.97, beat Q2 '26 estimate $1.09 Q2 '26 actual $1.21, beat Q3 '26 estimate $1.09 Q3 '26 actual $0.81, miss Q4 '26 estimate $1.14

Analyst Consensus ?

ConsensusBuy45 ratings
Bullish2657.8%
Neutral1737.8%
Bearish24.4%

Analyst 52W Price Targets

$80.38Previous close
$63Low
$79.81Average
$100High

Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Nov 2, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
TD Cowen Hold HoldMaintainOct 13, 2026
Wells Fargo Overweight OverweightMaintainOct 5, 2026
Barclays Equal Weight OverweightDowngradeJul 27, 2026
Morgan Stanley Overweight OverweightMaintainJul 2, 2026
JP Morgan Overweight OverweightMaintainMay 7, 2026
Evercore ISI Group Outperform OutperformMaintainFeb 13, 2026
Goldman Sachs Buy NeutralUpgradeMay 12, 2025
Citigroup Buy NeutralUpgradeOct 1, 2024
Exane BNP Paribas Neutral OutperformDowngradeJan 12, 2024
Jefferies Buy HoldUpgradeJan 10, 2024
B of A Securities Buy NeutralUpgradeSep 29, 2023
Deutsche Bank Buy HoldUpgradeJun 22, 2023
Redburn Partners Buy NeutralUpgradeNov 19, 2021
Argus Research Hold BuyDowngradeSep 30, 2021
CFRA Hold HoldMaintainMay 26, 2020
RBC Capital Outperform Sector PerformUpgradeMar 12, 2020
Credit Suisse Neutral OutperformDowngradeMar 9, 2020
Bryan Garnier Neutral BuyDowngradeFeb 28, 2020
Redburn Neutral SellUpgradeNov 18, 2019
UBS Neutral BuyDowngradeAug 6, 2019
Bank of America Buy NeutralUpgradeJul 29, 2019
Macquarie Neutral NeutralMaintainMar 1, 2019
Argus Hold BuyDowngradeNov 12, 2018
HSBC Buy HoldUpgradeJun 4, 2018
Bernstein Outperform Market PerformUpgradeMar 12, 2018
Investec Hold BuyDowngradeNov 17, 2016
Societe Generale Hold BuyDowngradeOct 20, 2016
Kepler Cheuvreux Buy HoldUpgradeAug 22, 2016
Susquehanna Neutral PositiveDowngradeAug 1, 2016
Berenberg Buy HoldUpgradeNov 13, 2015
CLSA Outperform UnderperformUpgradeNov 2, 2015
Ingalls & Snyder, LLC Buy HoldUpgradeAug 26, 2015
ING Buy HoldUpgradeAug 26, 2015
Stifel Nicolaus Buy BuyMaintainJul 31, 2015
Stifel Buy BuyMaintainJul 31, 2015
Nomura Neutral BuyDowngradeJul 21, 2015
Tigress Financial Underperform NeutralDowngradeMar 17, 2015
BTIG Research Neutral BuyDowngradeSep 9, 2014
BTIG Neutral BuyDowngradeSep 9, 2014
Rabobank Buy HoldUpgradeJul 31, 2013
Mirabaud Securities Accumulate NeutralUpgradeJul 31, 2013
Mirabaud Accumulate NeutralUpgradeJul 31, 2013
KBC Partners Accumulate HoldUpgradeJul 31, 2013
Canaccord Genuity Buy HoldUpgradeJul 31, 2013
Banco Sabadell Sell BuyDowngradeApr 30, 2013
Show less

Named analyst price targets

Upside is calculated against the persisted previous close $80.38. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Wells FargoChris Carey$97$86.14 +20.7%Jul 31, 2026
Morgan StanleyAnalyst unavailable$84.5$80.25 +5.1%Jul 1, 2026
Morgan StanleyAnalyst unavailable$82$74.39 +2.0%Apr 8, 2026
Evercore ISIAnalyst unavailable$100$79.4 +24.4%Feb 13, 2026
Wells FargoAnalyst unavailable$85$75.81 +5.7%Feb 9, 2026
Wells FargoAnalyst unavailable$75$61.16 -6.7%Nov 19, 2025
JefferiesEdward Mundy$74$59.85 -7.9%Sep 29, 2025
Argus ResearchAnalyst unavailable$70$62.14 -12.9%Mar 27, 2025
Morgan StanleySarah Simon$63$49.22 -21.6%Jan 9, 2025
Morgan StanleySarah Simon$73$63.66 -9.2%Sep 10, 2024
Morgan StanleySarah Simon$68.5$59.96 -14.8%Apr 8, 2024
BarclaysEddie Kim$65$60.2 -19.1%Mar 5, 2024
JefferiesEdward Mundy$76$66.15 -5.4%Jan 10, 2024
Show less

Track every rating change on BUD the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Anheuser-Busch InBev SA/NV (AB InBev) is a global beverage giant involved in the manufacturing, marketing, and retailing of a wide variety of beers, other alcoholic drinks, and soft drinks across the world. The company manages an expansive collection of around 500 beer labels. Its most prominent and globally recognized brands include Budweiser, Corona, and Stella Artois. Additionally, its portfolio features well-known names such as Beck's, Hoegaarden, Leffe, and Michelob Ultra, alongside a host of other popular brands like Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol. Established in 1366, AB InBev's corporate headquarters are situated in Leuven, Belgium.

Historical context

All BUD earnings

Consumer Defensive peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the BUD recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:55.686058+00:00
  3. Polygon adjusted daily market bars · 2026-11-02T12:20:45.917119+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-02T12:20:45.914289+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-11-02. For educational purposes only; not investment advice.